SPX3,963.51+29.59 0.75%
DIA338.46+2.02 0.60%
IXIC11,082.00+123.45 1.13%

--Canaccord Genuity Boosts Price Target on ImmunoGen to $15 From $12, Keeps Buy Rating

--Canaccord Genuity Boosts Price Target on ImmunoGen to $15 From $12, Keeps Buy Rating

MT Newswires · 11/16/2022 05:07

Please log in to view news